Featured Research

from universities, journals, and other organizations

University Of Pittsburgh Researchers Identify Subtype Of Cell That Promotes Organ Transplant Acceptance

Date:
May 22, 2001
Source:
University Of Pittsburgh Medical Center
Summary:
In one of the few studies of its kind, researchers from the University of Pittsburgh's Thomas E. Starzl Transplantation Institute have found that a subtype of dendritic cell plays a key role in preventing organ rejection and may be associated with transplant tolerance, the long-term survival of a transplanted organ without the need for immunosuppressant drugs.

CHICAGO, May 15 -- In one of the few studies of its kind, researchers from the University of Pittsburgh's Thomas E. Starzl Transplantation Institute have found that a subtype of dendritic cell plays a key role in preventing organ rejection and may be associated with transplant tolerance, the long-term survival of a transplanted organ without the need for immunosuppressant drugs.

Related Articles


Researchers will now be looking to see if the same cells are present in liver and kidney transplant recipients who have been successfully weaned off immunosuppression, patients who are essentially tolerant of their organs.

The findings are significant because dendritic cells, a rare type of white blood cell that is present in all tissues, have been thought only to be involved in prompting the rejection process, reported Peta J. O'Connell, Ph.D., at Transplant 2001, the joint meeting of the American Society of Transplantation (AST) and the American Society of Transplant Surgeons.

Dendritic cells are known for their ability to identify and present antigens, or foreign substances, to other immune system cells that are programmed to destroy the antigen. But according to Dr. O'Connell, some dendritic cells apparently regulate the immune response, determining that a frontline attack by T cells can be unwarranted.

Dr. O'Connell, a visiting research instructor working with Angus W. Thomson, Ph.D., D.Sc., reported that a pre-transplant infusion of lymphoid dendritic cell subtypes derived from tissue such as the spleen, allowed for prolonged survival in a mouse heart transplant model, even without the use of drugs to control rejection. In contrast, myeloid dendritic cells accelerated the rejection response.

"The lymphoid-derived dendritic cells somehow disarm immune system T cells from doing their part to attack the donor organ possibly by causing either their death or limiting their proliferation," explained Dr. O'Connell, who received an AST Young Investigator's Award for her work.

Based on these studies, the researchers plan to see if these "good" dendritic cells are present in liver and kidney transplant recipients who are off all immunosuppression as part of a larger effort to identify laboratory profiles and tests consistent with tolerance.

Through the Immune Tolerance Network, an ambitious undertaking supported by the National Institutes of Health and Juvenile Diabetes Foundation International, Dr. Thomson and Adriana Zeevi, Ph.D., are leading this unique study to better understand the specific immunological process that occurs in transplant patients who are off all drugs. Specifically, Drs. Thomson and Zeevi are looking at the role of dendritic cells in tolerance as well as key regulatory proteins within the immune system, where small changes in the code may reveal a patient's potential for rejection.

"This will provide a 'roadmap' for clinicians, to help identify those for whom immunosuppression can be safely withdrawn," said Dr. Thomson, professor of surgery and molecular genetics and biochemistry at the University of Pittsburgh School of Medicine and the Thomas E. Starzl Transplantation Institute.

"We'd like to identify the cellular and molecular clues so that assays, or very simple laboratory tests, can be developed that would be predictive of tolerance," added Dr. Zeevi, professor of pathology and surgery at Pitt's School of Medicine and the Starzl Transplant Institute.


Story Source:

The above story is based on materials provided by University Of Pittsburgh Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of Pittsburgh Medical Center. "University Of Pittsburgh Researchers Identify Subtype Of Cell That Promotes Organ Transplant Acceptance." ScienceDaily. ScienceDaily, 22 May 2001. <www.sciencedaily.com/releases/2001/05/010518081355.htm>.
University Of Pittsburgh Medical Center. (2001, May 22). University Of Pittsburgh Researchers Identify Subtype Of Cell That Promotes Organ Transplant Acceptance. ScienceDaily. Retrieved March 31, 2015 from www.sciencedaily.com/releases/2001/05/010518081355.htm
University Of Pittsburgh Medical Center. "University Of Pittsburgh Researchers Identify Subtype Of Cell That Promotes Organ Transplant Acceptance." ScienceDaily. www.sciencedaily.com/releases/2001/05/010518081355.htm (accessed March 31, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Tuesday, March 31, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Solitair Device Aims to Takes Guesswork out of Sun Safety

Solitair Device Aims to Takes Guesswork out of Sun Safety

Reuters - Innovations Video Online (Mar. 31, 2015) — The Solitair device aims to take the confusion out of how much sunlight we should expose our skin to. Small enough to be worn as a tie or hair clip, it monitors the user&apos;s sun exposure by taking into account their skin pigment, location and schedule. Matthew Stock reports. Video provided by Reuters
Powered by NewsLook.com
Soda, Salt and Sugar: The Next Generation of Taxes

Soda, Salt and Sugar: The Next Generation of Taxes

Washington Post (Mar. 30, 2015) — Denisa Livingston, a health advocate for the Dinι Community Advocacy Alliance, and the Post&apos;s Abby Phillip discuss efforts around the country to make unhealthy food choices hurt your wallet as much as your waistline. Video provided by Washington Post
Powered by NewsLook.com
UnitedHealth Buys Catamaran

UnitedHealth Buys Catamaran

Reuters - Business Video Online (Mar. 30, 2015) — The $12.8 billion merger will combine the U.S.&apos; third and fourth largest pharmacy benefit managers. Analysts say smaller PBMs could also merge. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
S. Leone in New Anti-Ebola Lockdown

S. Leone in New Anti-Ebola Lockdown

AFP (Mar. 28, 2015) — Sierra Leone imposed a three-day nationwide lockdown Friday for the second time in six months in a bid to prevent a resurgence of the deadly Ebola virus. Duration: 01:17 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins